Variant report

Variant	esv3337175
Chromosome Location	chr16:12191551-12195249
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:157)
CpG islands
(count:183)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:157 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:12193721-12194191	HepG2	liver:	n/a	n/a
2	ARID3A	chr16:12191183-12191858	HepG2	liver:	n/a	n/a
3	ATF1	chr16:12191470-12191757	K562	blood:	n/a	n/a
4	ATF3	chr16:12191377-12191752	K562	blood:	n/a	n/a
5	BHLHE40	chr16:12192568-12192621	K562	blood:	n/a	n/a
6	BHLHE40	chr16:12193689-12194269	HepG2	liver:	n/a	n/a
7	CCNT2	chr16:12191450-12191693	K562	blood:	n/a	n/a
8	CEBPB	chr16:12191449-12191720	K562	blood:	n/a	n/a
9	CEBPB	chr16:12191323-12191864	HepG2	liver:	n/a	n/a
10	CEBPB	chr16:12194014-12194214	HepG2	liver:	n/a	n/a
11	CEBPB	chr16:12191464-12191756	MCF-7	breast:	n/a	n/a
12	CEBPB	chr16:12191409-12191804	IMR90	lung:	n/a	n/a
13	CEBPB	chr16:12191253-12191802	HepG2	liver:	n/a	n/a
14	CEBPB	chr16:12191449-12191742	HepG2	liver:	n/a	n/a
15	CEBPB	chr16:12191624-12191653	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr16:12191439-12191895	MCF-7	breast:	n/a	n/a
17	CEBPB	chr16:12191408-12191807	HepG2	liver:	n/a	n/a
18	CEBPB	chr16:12191429-12191719	K562	blood:	n/a	n/a
19	CEBPB	chr16:12191449-12191751	K562	blood:	n/a	n/a
20	CEBPD	chr16:12191376-12191861	HepG2	liver:	n/a	n/a
21	CEBPD	chr16:12191452-12191690	HepG2	liver:	n/a	n/a
22	CHD2	chr16:12193941-12194080	HepG2	liver:	n/a	n/a
23	CHD2	chr16:12191540-12191916	HepG2	liver:	n/a	n/a
24	CHD2	chr16:12192315-12192390	HepG2	liver:	n/a	n/a
25	CTCF	chr16:12192700-12192850	GM06990	blood:	n/a	n/a
26	CTCF	chr16:12192740-12192890	MCF-7	breast:	n/a	n/a
27	CTCF	chr16:12192680-12192830	WERI-Rb-1	eye:	n/a	n/a
28	CTCF	chr16:12192712-12192848	MCF-7	breast:	n/a	n/a
29	CTCF	chr16:12193704-12193933	HepG2	liver:	n/a	n/a
30	CTCF	chr16:12192720-12192870	MCF-7	breast:	n/a	n/a
31	CTCF	chr16:12192700-12192850	HepG2	liver:	n/a	n/a
32	CTCF	chr16:12192715-12192864	H1-hESC	embryonic stem cell:	n/a	n/a
33	CTCF	chr16:12192640-12192790	SK-N-SH_RA	brain:	n/a	n/a
34	CTCF	chr16:12192689-12192918	K562	blood:	n/a	n/a
35	CTCF	chr16:12192620-12192770	Hela-S3	cervix:	n/a	n/a
36	CTCF	chr16:12192660-12192810	RPTEC	kidney:	n/a	n/a
37	CTCF	chr16:12192751-12192855	GM12891	blood:	n/a	n/a
38	CTCF	chr16:12192783-12192817	MCF-7	breast:	n/a	n/a
39	CTCF	chr16:12192784-12192816	MCF-7	breast:	n/a	n/a
40	CTCF	chr16:12192680-12192830	SAEC	small airway:	n/a	n/a
41	CTCF	chr16:12193720-12193870	HepG2	liver:	n/a	n/a
42	CTCF	chr16:12193796-12193912	HepG2	liver:	n/a	n/a
43	CTCF	chr16:12192716-12192826	K562	blood:	n/a	n/a
44	CTCF	chr16:12192780-12192930	HepG2	liver:	n/a	n/a
45	CTCF	chr16:12192800-12192950	HEK293	kidney:	n/a	n/a
46	CTCF	chr16:12192700-12192850	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr16:12192700-12192850	HRE	kidney:	n/a	n/a
48	CTCF	chr16:12192680-12192830	A549	lung:	n/a	n/a
49	CTCF	chr16:12192760-12192818	GM19238	blood:	n/a	n/a
50	CTCF	chr16:12193800-12193950	HepG2	liver:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:12192263-12192313	AG09309	skin:	n/a
2	chr16:12192263-12192313	MCF10A-Er-Src	breast:	n/a
3	chr16:12192430-12192480	NH-A	brain:	n/a
4	chr16:12192430-12192480	HPAEpiC	pulmonary alveolar:	n/a
5	chr16:12192263-12192313	HAEpiC	amniotic membrane:	n/a
6	chr16:12192325-12192375	ProgFib	skin:	n/a
7	chr16:12192263-12192313	SK-N-MC	brain:	n/a
8	chr16:12192263-12192313	NT2-D1	testis:	n/a
9	chr16:12192325-12192375	HCM	heart:	n/a
10	chr16:12192263-12192313	A549	lung:	n/a
11	chr16:12192430-12192480	Hela-S3	cervix:	n/a
12	chr16:12192325-12192375	AG09319	gingival:	n/a
13	chr16:12192430-12192480	HMEC	breast:	n/a
14	chr16:12192325-12192375	MCF10A-Er-Src	breast:	n/a
15	chr16:12192430-12192480	HEEpiC	esophagus:	n/a
16	chr16:12192325-12192375	H1-hESC	embryonic stem cell:	embryo
17	chr16:12192430-12192480	BJ	skin:	n/a
18	chr16:12192263-12192313	K562	blood:	n/a
19	chr16:12192325-12192375	PrEC	prostate:	n/a
20	chr16:12192263-12192313	U87	brain:	n/a
21	chr16:12192263-12192313	Jurkat	blood:	n/a
22	chr16:12192430-12192480	HCT-116	colon:	n/a
23	chr16:12192325-12192375	HUVEC	blood vessel:	n/a
24	chr16:12192325-12192375	LNCaP	prostate:	n/a
25	chr16:12192263-12192313	HRPEpiC	eye:	n/a
26	chr16:12192263-12192313	SK-N-SH	brain:	n/a
27	chr16:12192263-12192313	NHBE	bronchial:	n/a
28	chr16:12192263-12192313	ovcar-3	ovarian:	n/a
29	chr16:12192430-12192480	HCF	heart:	n/a
30	chr16:12192430-12192480	HNPCEpiC	eye:	n/a
31	chr16:12192430-12192480	GM12892	blood:	n/a
32	chr16:12192430-12192480	AG04449	skin:	fetal
33	chr16:12192325-12192375	SK-N-MC	brain:	n/a
34	chr16:12192263-12192313	BJ	skin:	n/a
35	chr16:12192325-12192375	Hepatocyte	liver:	n/a
36	chr16:12192430-12192480	NT2-D1	testis:	n/a
37	chr16:12192325-12192375	GM19239	blood:	n/a
38	chr16:12192325-12192375	HEEpiC	esophagus:	n/a
39	chr16:12192263-12192313	HRE	kidney:	n/a
40	chr16:12192263-12192313	NB4	blood:	n/a
41	chr16:12192430-12192480	T-47D	breast:	n/a
42	chr16:12192325-12192375	Jurkat	blood:	n/a
43	chr16:12192430-12192480	PrEC	prostate:	n/a
44	chr16:12192263-12192313	HCPEpiC	choroid plexus:	n/a
45	chr16:12192263-12192313	HCF	heart:	n/a
46	chr16:12192325-12192375	HRE	kidney:	n/a
47	chr16:12192430-12192480	HRCEpiC	kidney:	n/a
48	chr16:12192430-12192480	U87	brain:	n/a
49	chr16:12192325-12192375	HEK293	kidney:	embryo
50	chr16:12192430-12192480	H1-hESC	embryonic stem cell:	embryo

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:12194051..12195792-chr16:12311088..12313546,2	MCF-7	breast:
2	chr16:12193274..12196616-chr16:12197279..12199728,3	K562	blood:
3	chr16:12192648..12195630-chr16:12219371..12221424,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000261293	TF binding region
ENSG00000261293	CpG island

Extended variants
information (count: 170 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:170 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149266757	chr16:12191552-12191553	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs146194637	chr16:12191565-12191566	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs528860914	chr16:12191567-12191568	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs77169794	chr16:12191591-12191592	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs193291502	chr16:12191652-12191653	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs73517861	chr16:12191659-12191660	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs567938186	chr16:12191668-12191669	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs184317488	chr16:12191675-12191676	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs552989212	chr16:12191727-12191728	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs528379609	chr16:12191734-12191735	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs376697751	chr16:12191806-12191807	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs572842142	chr16:12191815-12191816	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs551133220	chr16:12191819-12191820	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs545043745	chr16:12191841-12191842	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs139090548	chr16:12191851-12191852	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs575252200	chr16:12191911-12191912	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs142301655	chr16:12191942-12191943	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs560970425	chr16:12191948-12191949	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs377494893	chr16:12191956-12191957	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs529976491	chr16:12191966-12191967	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs540105457	chr16:12191993-12191994	Weak transcription Enhancers Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs377436773	chr16:12192021-12192022	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs560040152	chr16:12192022-12192023	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs528424617	chr16:12192056-12192057	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs146033449	chr16:12192069-12192070	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs76105253	chr16:12192106-12192107	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs4781180	chr16:12192194-12192195	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs118056349	chr16:12192199-12192200	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs4780411	chr16:12192204-12192205	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs148683294	chr16:12192223-12192224	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs76991186	chr16:12192233-12192234	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs200991052	chr16:12192266-12192267	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs142181686	chr16:12192275-12192276	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs116562785	chr16:12192306-12192307	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs377690658	chr16:12192342-12192343	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs189042030	chr16:12192353-12192354	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs528934135	chr16:12192359-12192360	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs575292479	chr16:12192397-12192398	Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs151191749	chr16:12192405-12192406	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs370334153	chr16:12192415-12192416	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs572728128	chr16:12192430-12192431	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs574267524	chr16:12192436-12192437	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs535363980	chr16:12192437-12192438	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs374726975	chr16:12192454-12192455	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
45	rs3851011	chr16:12192472-12192473	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs578113410	chr16:12192474-12192475	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
47	rs370417674	chr16:12192479-12192480	Weak transcription Strong transcription Enhancers Genic enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs543684186	chr16:12192495-12192496	Weak transcription Strong transcription Enhancers Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs557016664	chr16:12192501-12192502	Weak transcription Strong transcription Enhancers Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs559978068	chr16:12192502-12192503	Weak transcription Strong transcription Enhancers Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Cancer	21183584	CNVD
Follicular lymphoma	20505157	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	17603634	CNVD
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Lung cancer	18438408	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22102821	CNVD
Autism	22495311	CNVD
idiopathic generalized epilepsy	19843651	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Intellectual disability	22102821	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelofibrosis	22110671	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Prostate cancer	18632612	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Lujan-Fryns syndrom	21521776	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	19786961	CNVD
Mental retardation	19786961	CNVD
Schizophrenia	19786961	CNVD
Mental retardation	19951919	CNVD
Autism	18791038	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Malignant germ cell tumour	17285132	CNVD
Autism	17480035	CNVD
Schizophrenia	19955444	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21858162	CNVD

Chromatin state (count:214 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:12178600-12199600	Weak transcription	Aorta	Aorta
2	chr16:12184000-12191600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr16:12184200-12192200	Weak transcription	Gastric	stomach
4	chr16:12184200-12193000	Enhancers	Fetal Thymus	thymus
5	chr16:12184400-12231200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
6	chr16:12186800-12213400	Weak transcription	Sigmoid Colon	Sigmoid Colon
7	chr16:12187000-12192200	Weak transcription	Primary monocytes fromperipheralblood	blood
8	chr16:12188000-12194400	Strong transcription	GM12878-XiMat	blood
9	chr16:12188200-12192000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr16:12188400-12193600	Enhancers	Placenta	Placenta
11	chr16:12188800-12192400	Enhancers	Fetal Stomach	stomach
12	chr16:12188800-12192400	Enhancers	Rectal Mucosa Donor 31	rectum
13	chr16:12189000-12192000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr16:12189000-12192000	Enhancers	Cortex derived primary cultured neurospheres	brain
15	chr16:12189000-12192000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr16:12189200-12191800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr16:12189200-12192000	Enhancers	Brain Substantia Nigra	brain
18	chr16:12189200-12192000	Enhancers	Left Ventricle	heart
19	chr16:12189200-12192000	Enhancers	Right Ventricle	heart
20	chr16:12189200-12192000	Enhancers	HSMM	muscle
21	chr16:12189200-12192000	Enhancers	NHEK	skin
22	chr16:12189200-12192200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr16:12189200-12192200	Enhancers	HSMMtube	muscle
24	chr16:12189200-12192400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr16:12189200-12192600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr16:12189200-12192600	Enhancers	Spleen	Spleen
27	chr16:12189600-12191800	Enhancers	Muscle Satellite Cultured Cells	--
28	chr16:12189600-12191800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
29	chr16:12189600-12192000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr16:12189600-12192400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr16:12189600-12192400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr16:12189600-12192400	Enhancers	Duodenum Mucosa	Duodenum
33	chr16:12189600-12192800	Enhancers	Brain Inferior Temporal Lobe	brain
34	chr16:12189600-12192800	Enhancers	Fetal Lung	lung
35	chr16:12189600-12193600	Weak transcription	H1 Cell Line	embryonic stem cell
36	chr16:12189600-12194000	Enhancers	Fetal Muscle Leg	muscle
37	chr16:12189600-12194000	Enhancers	Ovary	ovary
38	chr16:12189600-12204000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
39	chr16:12189600-12204800	Weak transcription	Primary hematopoietic stem cells	blood
40	chr16:12189600-12204800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr16:12189800-12191800	Enhancers	Small Intestine	intestine
42	chr16:12189800-12192000	Enhancers	Colon Smooth Muscle	Colon
43	chr16:12189800-12192000	Enhancers	Rectal Smooth Muscle	rectum
44	chr16:12189800-12192000	Enhancers	NHLF	lung
45	chr16:12189800-12192200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
46	chr16:12189800-12192200	Weak transcription	Primary T helper cells PMA-I stimulated	--
47	chr16:12189800-12192400	Enhancers	Brain Hippocampus Middle	brain
48	chr16:12189800-12192800	Weak transcription	Primary T cells from cord blood	blood
49	chr16:12189800-12192800	Enhancers	Brain Cingulate Gyrus	brain
50	chr16:12189800-12205000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links